The vast majority of diseases have no approved medicines despite the extraordinary developments in drug development technology. Furthermore, current efforts to reduce this gap are ineffective, prompting the need to investigate fresh and varied possible mechanisms in order to achieve success. An extensive library of distinct drug-like compounds may be found in medicinal plant molecules, which can be transformed into first-class small molecule medicines. In the search for novel, bioactive compounds in plants, the BIAltesse sophisticated technology platform has alleviated many of the previously mentioned hurdles, allowing for the rapid development of new, potent small molecule medicines.